Opus Genetics (IRD) Cash from Investing Activities (2010 - 2024)
Opus Genetics (IRD) reported Cash from Investing Activities of $1.2 million for Q4 2024, up 1310.0% on a QoQ basis from -$100000.0 in Q4 2021.
Opus Genetics (IRD) has 13 years of Cash from Investing Activities data on file, last reported at $1.2 million in Q4 2024.
- Quarterly Cash from Investing Activities changed N/A year-over-year to $1.2 million in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $1.2 million (changed N/A YoY) and the FY2024 annual result came in at $1.2 million, changed N/A from the prior year.
- Cash from Investing Activities grew to $1.2 million in Q4 2024 per IRD's latest filing, from -$100000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $1.2 million in Q4 2024 and bottomed at -$100000.0 in Q4 2021.
- The 3-year median for Cash from Investing Activities is $539000.0 (2020), against an average of $549666.7.
- The widest annual swing landed in 2020, when Cash from Investing Activities jumped 536.26%; it then plunged 118.55% in 2021.
- Tracing IRD's Cash from Investing Activities over 3 years: stood at $539000.0 in 2020, then sank by 118.55% to -$100000.0 in 2021, then surged by 1310.0% to $1.2 million in 2024.
- Per Business Quant, the three latest IRD Cash from Investing Activities figures stand at $1.2 million (Q4 2024), -$100000.0 (Q4 2021), and $539000.0 (Q4 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.21 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Dec 31, 2021 | -100,000.00 |
| Dec 31, 2021 | -100,000.00 |
| Dec 31, 2020 | 539,000.00 |
| Dec 31, 2020 | 539,000.00 |
| Dec 31, 2019 | -123,551.00 |
| Dec 31, 2019 | -123,551.00 |
| Sep 30, 2019 | 3.00 Mn |
| Sep 30, 2019 | 3.00 Mn |
| Jun 30, 2019 | 2.99 Mn |
| Jun 30, 2019 | 2.99 Mn |
| Mar 31, 2019 | -5.90 Mn |
| Mar 31, 2019 | -5.90 Mn |
| Dec 31, 2018 | 2.00 Mn |
| Dec 31, 2018 | 2.00 Mn |
| Sep 30, 2018 | 3.66 Mn |
| Sep 30, 2018 | 3.66 Mn |
| Jun 30, 2018 | 3.25 Mn |
| Jun 30, 2018 | 3.25 Mn |
| Mar 31, 2018 | 3.00 Mn |
| Mar 31, 2018 | 3.00 Mn |
| Dec 31, 2017 | -3.06 Mn |
| Dec 31, 2017 | -3.06 Mn |
| Sep 30, 2017 | 3.00 Mn |
| Sep 30, 2017 | 3.00 Mn |
| Jun 30, 2017 | -10.02 Mn |
| Jun 30, 2017 | -10.02 Mn |
| Mar 31, 2017 | 710,335.00 |
| Mar 31, 2017 | 710,335.00 |
| Dec 31, 2016 | 4.68 Mn |
| Dec 31, 2016 | 4.68 Mn |
| Sep 30, 2016 | -1.91 Mn |
| Sep 30, 2016 | -1.91 Mn |
| Jun 30, 2016 | 2.48 Mn |
| Jun 30, 2016 | 2.48 Mn |
| Mar 31, 2016 | -766,356.00 |
| Mar 31, 2016 | -766,356.00 |
| Dec 31, 2015 | -4.28 Mn |
| Dec 31, 2015 | -4.28 Mn |
| Sep 30, 2015 | 6.96 Mn |
| Sep 30, 2015 | 6.96 Mn |
| Jun 30, 2015 | 2.64 Mn |
| Jun 30, 2015 | 2.64 Mn |
| Mar 31, 2015 | 4.24 Mn |
| Mar 31, 2015 | 4.24 Mn |
| Dec 31, 2014 | -2.23 Mn |
| Dec 31, 2014 | -2.23 Mn |
| Sep 30, 2014 | -20.53 Mn |
| Sep 30, 2014 | -20.53 Mn |
| Jun 30, 2014 | 74,931.00 |
| Jun 30, 2014 | 74,931.00 |
| Mar 31, 2014 | 28,829.00 |
| Mar 31, 2014 | 28,829.00 |
| Dec 31, 2013 | 309,359.00 |
| Dec 31, 2013 | 309,359.00 |
| Sep 30, 2013 | 14,850.00 |
| Sep 30, 2013 | 14,850.00 |
| Jun 30, 2013 | 387,301.00 |
| Jun 30, 2013 | 387,301.00 |
| Mar 31, 2013 | 134,012.00 |
| Mar 31, 2013 | 134,012.00 |
| Dec 31, 2012 | -874,628.00 |
| Dec 31, 2012 | -874,628.00 |
| Sep 30, 2012 | 546,718.00 |
| Sep 30, 2012 | 546,718.00 |
| Jun 30, 2012 | 2.36 Mn |
| Jun 30, 2012 | 2.36 Mn |
| Mar 31, 2012 | 156,134.00 |
| Mar 31, 2012 | 156,134.00 |
| Dec 31, 2011 | 1.50 Mn |
| Dec 31, 2011 | 1.50 Mn |
| Sep 30, 2011 | 228,193.00 |
| Sep 30, 2011 | 228,193.00 |
| Jun 30, 2011 | 679,401.00 |
| Jun 30, 2011 | 679,401.00 |
| Mar 31, 2011 | -2.96 Mn |
| Mar 31, 2011 | -2.96 Mn |
| Dec 31, 2010 | -1.07 Mn |
| Dec 31, 2010 | -1.07 Mn |
| Sep 30, 2010 | -395,807.00 |
| Sep 30, 2010 | -395,807.00 |